Proton therapy reduces toxicity risk vs. IMRT in locally advanced esophageal cancer

Proton beam therapy appeared to reduce the risk for and severity of adverse events compared with intensity-modulated radiation therapy for patients with locally advanced esophageal cancer, according to results of a randomized phase 2B study published in Journal of Clinical Oncology.The modalities conferred similar rates of PFS and OS among this patient population.“The physical nature of particle therapy allows the dose deposition [to occur at a] very discrete and defined location within the beam line based on the energy of the beam; normal tissues beyond this point get very little to noRead More

Share on facebook
Share on twitter
Share on linkedin